Výsledky vyhledávání - Neal I. Lindeman
- Zobrazuji výsledky 1 - 20 z 90
- Přejít na další stránku
-
1
-
2
-
3
-
4
-
5
Targeted Next-Generation Sequencing Reveals Clinically Actionable <i>BRAF</i> and <i>ESR1</i> Mutations in Low-Grade Serous Ovarian Carcinoma Autor Elizabeth H. Stover, Colleen M. Feltmate, Ross S. Berkowitz, Neal I. Lindeman, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos
Vydáno 2018Artigo -
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Precision of Pyrosequencing Assay to Measure LINE-1 Methylation in Colon Cancer, Normal Colonic Mucosa, and Peripheral Blood Cells Autor Natsumi Irahara, Katsuhiko Nosho, Yoshifumi Baba, Kaori Shima, Neal I. Lindeman, Aditi Hazra, Eva Schernhammer, David J. Hunter, Charles S. Fuchs, Shuji Ogino
Vydáno 2010Artigo -
14
Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomas Autor Melanie Johncilla, Matthew D. Stachler, Joseph Misdraji, Mikhail Lisovsky, Masato Yozu, Neal I. Lindeman, Gregory Y. Lauwers, Robert D. Odze, Amitabh Srivastava
Vydáno 2018Artigo -
15
SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma Autor David L. Kolin, Fei Dong, Michele Baltay, Neal I. Lindeman, Laura E. MacConaill, Marisa R. Nucci, Christopher P. Crum, Brooke E. Howitt
Vydáno 2018Artigo -
16
Treatment-Related Toxicities in a Phase II Trial of Dasatinib in Patients with Squamous Cell Carcinoma of the Lung Autor Andrew M. Brunner, Daniel B. Costa, Rebecca S. Heist, Elizabeth Garcia, Neal I. Lindeman, Lynette M. Sholl, Geoffrey R. Oxnard, Bruce E. Johnson, Peter S. Hammerman
Vydáno 2013Artigo -
17
Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions Autor Geoffrey R. Oxnard, Peter Lo, Mizuki Nishino, Suzanne E. Dahlberg, Neal I. Lindeman, Mohit Butaney, David M. Jackman, Bruce E. Johnson, Pasi A. Jänne
Vydáno 2013Artigo -
18
Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in <i>EGFR</i> Wild-type Cancers Autor Kimio Yonesaka, Kreshnik Zejnullahu, Neal I. Lindeman, Alison J. Homes, David M. Jackman, Feng Zhao, Andrew M. Rogers, Bruce E. Johnson, Pasi A. Jänne
Vydáno 2008Artigo -
19
Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma Autor David Papke, Jonathan A. Nowak, Matthew B. Yurgelun, Alexander Frieden, Amitabh Srivastava, Neal I. Lindeman, Lynette M. Sholl, Laura E. MacConaill, Fei Dong
Vydáno 2018Artigo -
20
<i>EGFR</i>Mutation Is a Better Predictor of Response to Tyrosine Kinase Inhibitors in Non–Small Cell Lung Carcinoma Than FISH, CISH, and Immunohistochemistry Autor Lynette M. Sholl, Yun Xiao, Victoria A. Joshi, Beow Y. Yeap, Leigh‐Anne Cioffredi, David M. Jackman, Charles Lee, Pasi A. Jänne, Neal I. Lindeman
Vydáno 2010Artigo
Vyhledávací nástroje:
Související témata
Medicine
Biology
Cancer
Internal medicine
Genetics
Oncology
Cancer research
Pathology
Gene
Lung cancer
Mutation
Bioinformatics
Adenocarcinoma
Computational biology
Epidermal growth factor receptor
Colorectal cancer
Receptor
Precision medicine
KRAS
Gefitinib
Genome
Clinical trial
Targeted therapy
Biochemistry
Breast cancer
Computer science
Family medicine
Tyrosine kinase
Chromosome
Guideline